The GH Stack combines CJC-1295 and Ipamorelin, the two most widely researched growth hormone secretagogue peptides. CJC-1295 is a GHRH analogue that extends the half-life of growth hormone release pulses. Ipamorelin is a selective GHRP that triggers GH release with high selectivity and minimal side-effect profile in research. Each combo unit includes one vial of CJC-1295 and one vial of Ipamorelin 10mg. For in-vitro laboratory and research use only.
Research at a Glance
- What it is: A blend of two separate research peptides, CJC-1295 and Ipamorelin, combined in one vial.
- Researchers have studied the components for: growth hormone and IGF-1 release (CJC-1295), selective growth hormone release through the ghrelin receptor (Ipamorelin), and whether the body’s natural GH pulse pattern holds during steady signaling.
- Evidence level: A handful of small, mostly older human and animal studies on each compound alone. No published study tested this combined blend itself.
- The short version: These are two separately studied GH-axis compounds put in one vial for research convenience. Each was looked at on its own, mostly in small early trials, and the popular idea that pairing them adds up was not what those studies set out to measure. Combining them is a convenience, not a proven-better formula.
Reviews
There are no reviews yet.